| 000 | 01259 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250516203356.0 | ||
| 264 | 0 | _c20140608 | |
| 008 | 201406s 0 0 eng d | ||
| 022 | _a1879-0631 | ||
| 024 | 7 |
_a10.1016/j.lfs.2014.03.014 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCheng, Hao-Yuan | |
| 245 | 0 | 0 |
_aStudying the enhancement of programmed cell death by combined AG1024 and paclitaxel in a model of chronic myelogenous leukemia. _h[electronic resource] |
| 260 |
_bLife sciences _cMay 2014 |
||
| 300 |
_a118-26 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents, Phytogenic _xadministration & dosage |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aDrug Delivery Systems _xmethods |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aK562 Cells |
| 650 | 0 | 4 |
_aLeukemia, Myelogenous, Chronic, BCR-ABL Positive _xdrug therapy |
| 650 | 0 | 4 |
_aPaclitaxel _xadministration & dosage |
| 650 | 0 | 4 |
_aTyrphostins _xadministration & dosage |
| 650 | 0 | 4 |
_aUp-Regulation _xdrug effects |
| 700 | 1 | _aKo, Fu-Hsiang | |
| 773 | 0 |
_tLife sciences _gvol. 102 _gno. 2 _gp. 118-26 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.lfs.2014.03.014 _zAvailable from publisher's website |
| 999 |
_c23666143 _d23666143 |
||